Facts About WB403 Revealed
data demonstrating TGR5 modulation and GLP-one activation ability, glucose tolerance enhancement, preservation for mass and function of pancreatic β-cells, in addition to absence of gallbladder filling side impact, represented a promising novel candidate for anti-diabetic drug development. The identification and characterization of WB403 not only